Reporting on banking news in the world
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
4 hours ago
HSBC supports UAE study abroad planning
3 hours ago
JPMorgan says Iran war could push US gas to $5
As featured in:
@ Journalists!
Join
Press releases
Publish your press release
May. 8, 2026
Merit Medical to Participate in the Bank of America Healthcare Conference
GlobeNewswire, Inc.
SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America...
May. 8, 2026
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
GlobeNewswire, Inc.
WAYNE, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday...
May. 8, 2026
Trade in services under regulatory barriers: evidence from UK banking
Bank of England
Shania Bhalotia, Sophie Piton and John Woods Barriers to trade in services remain poorly understood.
May. 7, 2026
LeMaitre to Present at the Bank of America Healthcare Conference
GlobeNewswire, Inc.
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT. About LeMaitre LeMaitre...
May. 7, 2026
Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
GlobeNewswire, Inc.
NEWTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s...
May. 7, 2026
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
GlobeNewswire, Inc.
WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global...
Video Stories
Discover Affinity Group Publishing
Sign up for:
Today in Banking
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
